Search

everythinglearnresearchcommunity

for

Search:↓

Non-hormonal treatments should be used first for sexual dysfunction in postmenopausal breast cancer patients on aromatase inhibitors, with hormones as a second option.

Four new cases of gynecomastia (male breast enlargement) linked to finasteride (Propecia) have been found.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Eating high-glycemic and dairy foods can increase hormones that may cause acne and other health issues.

Dihydrotestosterone can be made from dehydroepiandrosterone in skin cells without needing testosterone.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Thujae occidentalis semen extract may help treat male pattern baldness by blocking a hair loss-related enzyme and reducing hair loss in mice.

Hair changes could indicate neurological diseases and help monitor treatment.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Metformin is less effective in men with early-onset hair loss.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Glucocorticoids are powerful anti-inflammatory drugs that must be used carefully to avoid serious side effects.

RNA aptamers can specifically block FGF5-related cell growth, potentially treating related diseases or hair disorders.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Finasteride reduces hair growth and is safe for women with excessive hair.

The new progesterone derivatives effectively inhibit 5α-reductase and bind to the androgen receptor.

Use some skin medications with caution during pregnancy; avoid strong steroids, certain eczema treatments, and systemic retinoids, but many topical treatments and nasal sprays are safe.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Finasteride treats hair loss but may cause low libido, erectile issues, and depression.

Pregnenolone might help manage movement issues caused by Parkinson's disease treatment without reducing the medicine's effectiveness.

Different methods accurately measure Finasteride in medicines and body fluids.

New treatments for male hypogonadism are effective and should be personalized.

Sex hormones affect hair growth and loss, and treatments for related hair diseases include various medications, hair transplantation, and light therapy.